Introduction {#sec1-1}
============

Stem cells are immature, undifferentiated cells that can divide and multiply for an extended period of time, differentiating into specific types of cells and tissues.\[[@ref1]\] They are defined as cells that self-replicate and are able to differentiate into at least two different cell types. Both criteria must be present for a cell to be called a 'stem cell'.\[[@ref2]\] Discoveries in stem cell research present an opportunity for scientific evidence that stem cells, whether derived from adult tissues or the earliest cellular forms, hold great promise that goes far beyond regenerative medicine. Dentists are at the forefront of engaging their patients in potentially life-saving therapies derived from their own stem cells located either in deciduous or permanent teeth.

In 2000, the National Institute of Health mentioned the discovery of adult stem cells in the impacted third molars and even more resilient stem cells in the deciduous teeth, thus providing the prospect of regeneration of dentin and/or dental pulp; biologically viable scaffolds will be used for replacement of the orofacial bone and cartilage and defective salivary glands, which can be partially or completely regenerated.\[[@ref1]\]

Tooth banking is based on the firm belief that personalized medicine is the most promising avenue for treating challenging diseases and injuries that would occur throughout life. Individuals have different opportunities at different stages of their life for banking their valuable cells. Recent studies have shown that stem cells from human exfoliated deciduous teeth (SHED) have a greater ability to develop into various types of body tissues compared to other types of stem cells.

Methods of Literature Search {#sec1-2}
============================

The literature was searched using Pubmed and electronic data bases from 1999 to 2011. Key words such as stem cells, banking, SHED, and regeneration were used. The search was restricted to English language articles, published from 1999 to 2011, and various *in vivo* and *in vitro* studies were included. The purpose of this review was to highlight the application of stem cells in various fields of dentistry, with emphasis on its banking.

The principle stem cells are of two types:

Embryonic stem cells {#sec2-1}
--------------------

They are derived from cells of the inner cell mass of the blastocysts, during embryonic development. They are pluripotent, with the blastocyst being the early stage embryo consisting of approximately 50-150 cells, and give rise to all derivatives of three primary germ layers, that is, ectoderm, endoderm, and mesoderm. When given sufficient and necessary stimulation for a specific cell type, they can develop into more than 200 cell types of the adult body, but they do not contribute to the extra embryonic membrane or placenta. The most important and potential use of embryonic stem cells (ESC), is clinically in transplantation medicine, where they can be used to develop cell replacement therapies.\[[@ref1][@ref2][@ref3][@ref4]\]

The FDA-approved human trials using ESC for treatment of paralysis from a spinal cord injury\[[@ref5]\] and diseases of the eye have been reported.\[[@ref6]\]

Adult stem cells {#sec2-2}
----------------

Adult stem cells are multipotent, because their potential is normally limited to one or more lineages of specialized cells.\[[@ref3]\] They are not subject to the ethical controversy that is associated with ESC.\[[@ref1]\]

The adult stem cells can be recovered from the following:

Bone marrow--derived mesenchymal stem cells: Bone marrow transplants were the first successful stem cell therapies. Presently peripheral blood stem cell collection is being used in place of bone marrow aspiration.\[[@ref7]\]Adipose-derived adult stem cells: Have also been isolated from human fat, usually by the method of liposuction.\[[@ref8]\]Umbilical cord stem cells: Are derived from the blood of the umbilical cord.\[[@ref9][@ref10]\]Amniotic fluid--derived stem cells: Can be isolated from the aspirates of amniocentesis during genetic screening or collection at the time of delivery.\[[@ref11]\]Induced pluripotent stem cells: Refer to adult or somatic stem cells that have been genetically reprogramed to behave like ESC. Takahashi (2006)\[[@ref12]\] reported a generation of iPS from mouse embryonic fibroblasts and adult mouse tail-tip fibroblasts by the retrovirus-mediated transfection of four transcription factors, namely Oct3/4, Sox2, c-Myc, and Klf4, but it was Oct 4, Sox2, Nanog, and Lin28 according to Yu, *et al*. (2007).\[[@ref13]\] Takahashi (2007)\[[@ref14]\] demonstrated the generation of iP cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells expressed stem cell markers and are capable of generating cells characteristic of all three germ layers.Successful reprograming of differentiated human somatic cells into a pluripotent state would allow the creation of patient-and disease-specific stem cells, thus showing the capacity to generate a large quantity of stem cells as an autologous cell source, which can be used to regenerate patient-specific tissues and they also appear to minimize the need for ES cells.Various techniques have been used to alter gene expression in stem cells, which include, cell transfection via electroporation, lipid-mediated delivery or biolistics particle delivery, as well as cell transduction through viral-mediated gene delivery.\[[@ref15]\]Transfection and nucleofection methods have been tried in the laboratory using plasmids, with an enhanced green fluorescence protein (eGFP) as a reporter.\[[@ref16]\]Dental stem cells: Are the most accessible stem cells. They are isolated from the dental pulp of healthy teeth, both primary and permanent teeth, the periodontal ligament, including the apical region of developing teeth, and other tooth structures. Craniofacial stem cells, including dental stem cells (DSC), originate from neural crest cells and mesenchymal cells during development.\[[@ref17]\]Two major cell types are involved in dental hard tissue formation: Epithelium - derived ameloblasts that form enamel and the mesenchymal - originated odontoblasts that is responsible for the production of dentin.\[[@ref18]\]

Epithelium stem cells {#sec2-3}
---------------------

Although significant progress has been made with mesenchymal stem cells, there is no information available on the use of Epithelium stem cells in humans, because their ameloblasts and ameloblast precursors are eliminated soon after eruption.\[[@ref18]\] Stem cell technology appears to be the only possibility to re-create an enamel surface.\[[@ref18][@ref19]\]

Mesenchymal stem cells {#sec2-4}
----------------------

Mesenchymal stem cells (MSC) possess a high self-renewal capacity and the potential to differentiate into mesodermal lineages, thus forming cartilage, bone, adipose tissue, and skeletal muscle, and participate in the formation of many craniofacial structures.\[[@ref20]\] It can be used autologously without concern of immunorejection, as it can be isolated from patients who need the treatment.\[[@ref1]\] MSC have been used allogenically to heal large defects.\[[@ref2][@ref21]\]

The following dental mesenchymal progenitors have been used for tooth engineering purposes:\[[@ref4][@ref22][@ref23]\]

### SHED {#sec3-1}

These cells are immature, unspecialized cells in the teeth that are able to grow into specialized cell types by a process called 'differentiation'. In 2003, Miura *et al*., isolated cells from the deciduous dental pulp, which were highly proliferative and clonogenic.\[[@ref24]\] Abbas *et al*., 2008,\[[@ref19]\] investigated that SHED Teeth were of neural crest origin. SHEDs were found to express early mesenchymal stem cell markers (STRO-1 and CD146).\[[@ref25]\] These cells exhibited high plasticity, as they could differentiate into adipocytes,\[[@ref18][@ref24][@ref26][@ref27]\] chondontocytes, osteoblasts,\[[@ref24][@ref28][@ref29]\] and neurons *in vitro*.\[[@ref26][@ref27][@ref30][@ref31]\] \[[Figure 1](#F1){ref-type="fig"}\]. After *in vivo* implantation, the SHED cells could induce bone or dentin formation, but in contrast to dental pulp stem cells (DPSC), they failed to produce a dentin-pulp complex and represented an immature population of multipotent stem cells.\[[@ref18][@ref24][@ref27]\]

![SHED-derived mesenchymal stem cells](AMHSR-3-245-g001){#F1}

### Adult DPSCs {#sec3-2}

Adult DPSCs are isolated from adult dental pulp\[[@ref1][@ref2][@ref32]\] and contain precursors capable of forming odontoblasts under appropriate signals like calcium hydroxide or calcium phosphate materials, which contain pulp capping materials used by a dentist for treatment. The *in vivo* therapeutic targeting of these adult stem cells remains to be explored.\[[@ref2]\]

### Periodontal ligament stem cells {#sec3-3}

Periodontal ligament stem cells (PDLSCs) have a multilineage differentiation potential and are able to undergo adipogenic, osteogenic, and chondrogenic phenotype *in vivo*.\[[@ref26]\] PDLSCs are isolated from the separated PDL of the roots of the impacted human third molar and are found to express STRO-1 and CD146.\[[@ref16][@ref27]\] Seo, *et al*.,\[[@ref33]\] 2004, has demonstrated that PDL itself contains progenitors that can be activated to self-renew and regenerate other tissues like cementum and alveolar bone.\[[@ref18][@ref32]\] However, they formed sparse calcified nodules compared to DPSCs.\[[@ref4]\]

### Stem cells from the apical part of the papilla {#sec3-4}

In 2006, Sonoyama *et al*.,\[[@ref34]\] isolated a new population of dental stem cells, and called them stem cells from the apical part of the papilla (SCAPs). SCAPs are clonogenic fibroblast-like cells, but have a higher proliferation rate than DPSCs. Similar to other dental stem cells, SCAPs express the early mesenchymal surface markers, STRO-1 and CD146.\[[@ref27]\] As in the case of DPSCs, when SCAPs were transplanted into immunocompromised mice in an appropriate carrier matrix, a typical dentin pulp--like structure was formed, with odontoblast-like cells.\[[@ref18][@ref27]\]

### Stem cells from the dental follicle {#sec3-5}

In 2005, Morsczeck *et al*.,\[[@ref35]\] isolated Stem Cells from the dental follicle of human third molars, which expressed the stem cell markers Notch1, STRO-1, and nestin.\[[@ref18][@ref27]\] An *In vitro* study demonstrated the potential of DFPCs to undergo osteogenic, adipogenic, and neurogenic differentiation.\[[@ref27]\] After *in vivo* implantation, the immortalized dental follicle cells were able to recreate a new periodontal ligament (PDL).\[[@ref36]\]

### Bone marrow-derived mesenchymal stem cells {#sec3-6}

Bone marrow-derived mesenchymal stem cells (BMSC) originate from the mesoderm.\[[@ref18]\] They can be obtained from several other sources such as the synovial membrane\[[@ref37]\] and periosteum,\[[@ref38]\] but it remains to be explored as to which source can be used for optimal tooth development, for clinical application. BMSC are able to form *in vivo* cementum, PDL, and alveolar bone, after implantation into defective periodontal tissues. Thus, they provide an alternative source of MSC for the treatment of periodontal diseases.\[[@ref39]\]

Tooth stem cells have an advantage over ESC in treating diseases, because they are less likely to develop into teratomas (tumors) when transplanted. However, the limitation of using DSC is that it is difficult to harvest a large quantity of stem cells from the teeth, the requirement of a professional technician is higher for extraction, isolation, and culture, and it also takes a longer time to culture mesenchymal stem cells from the teeth-active tissue.\[[@ref40]\]

Banking of dental stem cells {#sec2-5}
----------------------------

The key to successful stem cell therapy is to harvest cells and store them safely until accident or disease requires their usage. Tooth banking is not very popular, but the trend is catching up, mainly in the developed countries.\[[@ref26]\]

In the year 2003, Dr. Songtao Shi, a pediatric dentist, was able to isolate, grow, and preserve tooth stem cell\'s regenerative ability, by using the deciduous teeth of his six-year-old daughter.\[[@ref24]\] He called the cells as SHED. The existing research has shown that primary teeth are a better source of therapeutic stem cells for use in regenerative medicine than wisdom teeth, and orthodontically extracted teeth.\[[@ref29]\]

Advantages of SHED banking {#sec2-6}
--------------------------

Provides an autologous transplant for lifeSimple and painless procedure\[[@ref24]\]SHED cells are complementary to stem cells from the cord blood\[[@ref29]\]Useful for close relatives of the donor.\[[@ref3]\]Not subjected to the same ethical concerns as embryonic stem cells.\[[@ref2][@ref3]\]

Collection, Isolation, and Preservation {#sec1-3}
=======================================

For deciduous teeth, the best candidates for isolation are canines and incisors with the presence of healthy pulp that is starting to loosen. Adolescents have two excellent opportunities for banking, following extraction of bicuspid teeth for orthodontic treatment and at the time of extraction of wisdom teeth. The follicular sac of an unerupted tooth is also a valuable source for stem cells.\[[@ref3][@ref26]\]

Step 1: Tooth collection {#sec2-7}
------------------------

First step is to place the tooth in sterile saline solution,\[[@ref26]\] or in fresh milk, in a storage container along with frozen gel packs, in a Kit, which is then ready for delivery to the laboratory.\[[@ref41]\] The exfoliated tooth should have a pulp red in color, indicating that the pulp has received blood flow up until the time of removal, which is indicative of cell viability. The gray color of the pulp indicates that the blood flow is compromised, and thus the stem cells are likely to be necrotic and are no longer viable for recovery. With the recovery of the tooth it is transferred into a vial containing hypotonic phosphate buffered saline solution, which helps to prevent the tissue from drying during transport (up to four teeth in one vial). The vial is then carefully sealed and placed into a thermette (a temperature phase change carrier), which is then placed into an insulated metal transport vessel. This procedure maintains the sample in a hypothermic state during transportation, which is known as 'sustentation'.\[[@ref26]\]

Step 2: Stem cell isolation {#sec2-8}
---------------------------

When the tooth bank receives the Kit or vial, all the cells are isolated and a stringent protocol is followed for cleaning the tooth surface by various disinfectants. The pulp tissue is isolated from the pulp chamber and the cells are then cultured in a MSC medium, under appropriate conditions.\[[@ref24][@ref26]\] By making changes in the MSC medium different cell lines can be obtained such as odontogenic, adipogenic, and neural. If contamination is extensive, then a change in procedures can be performed using STRO 1 or CD 146.\[[@ref26]\] The time from harvesting to arrival at the processing storage facility should not exceed 40 hours.

Step 3: Stem cell storage {#sec2-9}
-------------------------

Either of the following approaches can be used.

*Cryopreservation*:\[[@ref26][@ref41][@ref42][@ref43]\] cells are preserved in liquid nitrogen vapor at −150° thus maintaining their latency and potency so that the cells can be stored for a long time and still remain viable for use.*Magnetic freezing*:\[[@ref26][@ref44]\] or the Cell Alive System (CAS), uses a magnetic field, where the object is chilled below freezing point, which ensures distributed low temperature without damaging the cell wall. The Hiroshima University claims that this can increase the cell survival rate in teeth to a high of 83%.

Licensed tooth stem cell banks, Internationally and in India, used for cryopreservation and isolation are as follows:\[[@ref26][@ref45]\]

In Japan, the first tooth bank was established in Hiroshima University and the company was named as 'Three Brackets' (Suri Buraketto).BioEden (Austin, Texas), StemSave, and Store-a-Tooth (USA)The norwegian tooth bankIn India, Stemade Biotech Pvt. Ltd. (Delhi, Chennai, Chandigarh, Pune, and Hyderabad).

Tooth regeneration {#sec2-10}
------------------

Langer and Vacanti first described tissue engineering as, 'an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function'.\[[@ref46]\] Although there can be many differing definitions of regenerative medicine, in practice, the term has come to represent applications that repair or replace structural and functional tissues, including bone, cartilage, and blood vessels, among organs and tissues.\[[@ref47]\] Tissue engineering is based on the principles of molecular developmental biology governed by bioengineering.\[[@ref46][@ref48][@ref49][@ref50]\] The three main components for morphogenesis and tissue engineering are: Inductive signals, responding cells, and a scaffold.\[[@ref49][@ref50][@ref51][@ref52][@ref53]\]

Currently there are two major approaches to tooth regeneration.\[[@ref54]\]

By using the principles of tissue engineeringBy reproducing the developing processes of embryonic tooth formation

The Yelick group used dental epithelium and mesenchymal tissues to seed heterogenous single cells onto a scaffold-like polycoglycolic polymer resulting in tiny tooth-like tissues (enamel, dentin, and pulp), but further studies are required to achieve reconstituted and structurally sound teeth.\[[@ref55]\]

Hu, *et al*.,\[[@ref56]\] have shown that BMC can give rise to ameloblast-like cells, while Sharpe\'s, *et al*.,\[[@ref57]\] reported that BMC, when placed in contact with the oral epithelium, can differentiate into dental mesenchymal cells, that is, dentin and pulp.

Sonoyama, *et al*.\[[@ref34]\] and Huang, *et al*.,\[[@ref58]\] explored that in miniature pigs, the bio-root periodontal complex is built up by postnatal stem cells using SCAP and PDLSC, to which an artificial porcelain crown is fixed, and concluded that dental stem cells engineering can be used for tooth root regeneration.

Ikeda, *et al*.,\[[@ref59]\] explored in adult mouse that fully functioning tooth replacement can be achieved by transplantation of a bioengineered tooth germ into an alveolar bone of a lost tooth region by the interaction between the dental epithelium and mesenchymal cells. The bioengineered tooth, which had erupted and reached occlusion, had the correct tooth structure and hardness of mineralized tissues for mastication.

As suggested by Nakahara and Idle,\[[@ref60]\] there are few limitations in tooth regeneration.

Principles of tissue engineering, related to tooth regeneration, which might not mimic tooth morphology.

At the present time there is no embryonic environment that enables bone marrow cells to differentiate into tooth germ cells.

Also, host immune rejection and ethical issue on the use of human embryo still exist to date.

Application in Interdisciplinary Dentistry {#sec1-4}
==========================================

Uses in endodontics {#sec2-11}
-------------------

Based on the basic tissue engineering principles,\[[@ref61][@ref62][@ref63][@ref64]\] Peter Murray *et al*.,\[[@ref61]\] identified several major areas of research that might have applications in the development of these techniques, which are: \[[Figure 2](#F2){ref-type="fig"}\]

![Uses of dental stem cells in dental tissue regeneration](AMHSR-3-245-g002){#F2}

### Concept of root canal revascularization via blood clotting {#sec3-7}

Several case reports have documented revascularization\[[@ref65][@ref66]\] of the necrotic root canal systems by disinfection followed by establishing bleeding into the canal system\[[@ref58]\] via overinstrumentation.\[[@ref67][@ref68][@ref69]\] Use of intracanal irrigants (NaOCl and chlorhexdine) along with the placement of antibiotics (e.g., a mixture of ciprofloxacin, metronidazole, and minocycline paste), for several weeks, is a critical step, as it effectively disinfects the root canal systems and increases revascularization of the avulsed and necrotic teeth. The revascularization process offers negligible chances of immune rejection and pathogen transmission, as regeneration of the tissue takes place by the patient\'s own blood cells. However, some critical limitations of this technique entail that caution is required, as the source of regenerated tissue has not been identified and also the concentration and composition of cells trapped in the fibrin clot are unpredictable.\[[@ref61]\] Animal and more clinical studies are required, to investigate the potential of this technique, before it can be recommended for general use in patients.

### Postnatal stem cell therapy {#sec3-8}

The process comprises of postnatal stem cells (derived from skin, buccal mucosa, fat, and bone)\[[@ref70]\] being injected into disinfected root canal systems after the apex is opened. This process has many advantages like the harvesting and delivery of autogenous stem cells by syringe, being relatively easy; and the potential of these cells to induce new pulp regeneration.\[[@ref61]\] However, there are several disadvantages, like the cells may have a low survival rate and they may migrate to different locations within the body.\[[@ref71]\] Instead, all three elements (cells, growth factors, and scaffold) must be considered, to maximize the potential for success of pulp regeneration.\[[@ref61][@ref72]\]

### Pulp implantation {#sec3-9}

The pulp cells can be grown on biodegradable membrane filters to transform two-dimensional into three-dimensional cell cultures.\[[@ref73]\] The ease of growing these cells on filters in the laboratory, for evaluation of cytotoxicity of test materials, is recognized as the main advantage of this delivery system. The potential problems associated with the implantation of sheets of cultured pulp tissue is that it requires specialized procedures for proper adherance to the root canal walls. As sheets of cells lack vascularity, only the apical portion of the canal systems will receive these cellular constructs, with coronal canal systems filled with scaffolds capable of supporting cellular proliferation.\[[@ref61]\]

### Scaffold implantation and delivery {#sec3-10}

A scaffold should contain growth factors, Bone Morphogenic Protein (BMP), fibroblast growth factors, and Vascular endothelial growth factors,\[[@ref74]\] to aid stem cell proliferation and differentiation, apart from having nutrients promoting cell survival and growth as well as antibiotics to prevent any bacterial in-growth in the canal systems. The scaffold materials may be natural or synthetic, biodegradable or permanent. The synthetic materials like polylactic acid, polyglycolic acid, and polycaprolactone degrade within the human body and have been succesfully used for tissue engineering purposes.\[[@ref75]\] Limitations consist of difficulties of obtaining high porosity and regular pore size.\[[@ref76]\]

Hydrogels are injectable scaffolds that can be delivered by syringe\[[@ref77][@ref78]\] and have the potential to be noninvasive and easy to deliver into root canal systems. Despite these advances they are at an early stage of research. To make hydrogels more practical, research is focusing on making them photopolymerizable to form rigid structures once they are implanted into the tissue site.\[[@ref79]\]

### Three-dimensional cell printing {#sec3-11}

The three-dimensional cell printing technique can be used to precisely position cells so that they have the potential to create tissue constructs that mimic the natural tooth pulp tissue structure \[[Figure 2](#F2){ref-type="fig"}\].\[[@ref80]\]

Careful orientation of the pulp tissue construct during placement into the cleaned and shaped root canal systems in accordance with its apical and coronal asymmetry is the prime requisite for the success of the technique. However, early research has yet to show that three-dimensional cell printing can create functional tissue *in vivo*.\[[@ref61][@ref81]\]

### Gene therapy {#sec3-12}

This technique involves a gene encoding a therapeutic protein being introduced into the cells, which can then express the target protein.\[[@ref82][@ref83][@ref84][@ref85][@ref86]\] A recent review has discussed the use of gene delivery in regenerative endodontics.\[[@ref49]\] Rutherford,\[[@ref87]\] in his study, used ferret pulps with cDNA (complementary DNA)-transfected mouse BMP-7, but failed to produce a reparative response, suggesting further research in the potential of pulp gene therapy. Although viral delivery systems have been used successfully in a broad range of tissues, they have serious health hazards, including the risks for mutagenesis, carcinogenesis, and invoking immune reactions in response to viral infection or viral proteins.\[[@ref61]\] At this time the potential benefits and disadvantages are largely therotical.\[[@ref61][@ref88]\]

Huang, *et al*. explored in mice that pulp-like tissue can be regenerated *de novo* in an emptied root canal space by stem cells from apical papilla and dental pulp that give rise to odontoblast-like cells, producing dentin-like tissue on the existing dentinal walls via stem/progenitor cell-based approaches and tissue engineering technologies.\[[@ref89]\]

Uses in periodontology {#sec2-12}
----------------------

The use of growth and differentiation factors for regenerating periodontal tissue is the most popular tissue engineering approach. To date several growth factors including Transfoming growth factors-β (TGF-β) superfamily members, such as, bone morphogenetic protein-2 (BMP-2), BMP-6, BMP-7, BMP-12, TGF-β, basic fibroblast growth factors (bFGF), and platelet derived growth factors (PDGF), have been used as a protein-based approach to regenerate periodontal tissues.\[[@ref90][@ref91][@ref92][@ref93][@ref94][@ref95][@ref96][@ref97]\] Several preclinical studies using MSCs have shown efficient reconstruction of bone defects larger than those that would spontaneously heal.\[[@ref1][@ref21]\] Kramer, *et al*.,\[[@ref98]\] demonstrated that PDL-like tissue can be developed from periodontal progenitor cells and from mesenchymal stem cells in contact with either PDL factors or the tissue itself. Kawaguchi and colleagues 2004,\[[@ref38]\] used bone marrow−derived MSCs in combination with atelocollagen for regeneration of periodontal tissues in class III furcation defects, in dogs, and concluded that additional studies would be required using different scaffold materials and a various range of cell concentration to obtain conclusive results.\[[@ref82]\] Although encouraging results for periodontal tissue regeneration have been found in numerous clinical investigations, limitation xists, with topical protein delivery. Dual growth factor delivery technologies could be useful in periodontal tissue engineering.\[[@ref82]\]

Uses in oral maxillofacial surgery for craniofacial reconstruction {#sec2-13}
------------------------------------------------------------------

Stem cells have been used in the tissue engineering of a human-shaped temporomandibular joint.\[[@ref1][@ref4][@ref99]\] Alhadlaq and Mao,\[[@ref21][@ref100]\] used MSC-derived cells encapsulated in a poly {ethylene glycol} diacrylate hydrogel that was molded into an adult human mandibular condyle in stratified yet integrated layers of cartilage and bone. The osteochondral grafts, in the shape of human TMJs, were implanted in immunodeficient mice for up to 12 weeks. Upon harvest, the tissue-engineered mandibular joint condyles retained their shape and dimensions.\[[@ref1]\]

According to Pittenger, *et al*.,\[[@ref101][@ref102]\] bone marrow--derived MSC are now under consideration for the repair of craniofacial bone and even the replacement or regeneration of oral tissues.\[[@ref1][@ref103]\] Reconstruction of craniofacial and dental defects using MSC avoids many of the limitations of both auto- and allografting techniques.\[[@ref99]\] Clinical studies are being conducted using stem cells for alveolar ridge augmentation and long-bone defects.\[[@ref103][@ref104]\] Vascularized bone grafts are also used in development using stem cells, and reconstruction of a patient\'s resected mandible has been carried out using this technique \[[Figure 2](#F2){ref-type="fig"}\].\[[@ref105]\]

Changes in the expression of stem cell markers in oral mucosal lesions and oral squamous cell carcinoma {#sec2-14}
-------------------------------------------------------------------------------------------------------

Despite the pivotal role of stem cells in the homeostasis of oral epithelium, the location of this cell population within the tissue is uncertain. How disease influences these cells *in vivo* also remains to be elucidated.

Kose, *et al*.,\[[@ref106]\] 2007, in a study, described the expression of six putative stem cell markers, that is, α 6 and β 1 integrins, melanoma-associated chondroitin sulfate proteoglycan (MCSP), NG2 the rat homolog of human MCSP, notch 1, and keratin 15 (k15), in normal buccal epithelium and showed their expression to be altered in oral mucosal diseases, oral lichen planus, and oral hyperkeratotic lesions. This suggest that stem cell marker expression may be altered by pathological signaling in these lesions. Further studies of these molecular perturbations are essential to understand the fundamental role of adult stem cells in the pathogenesis of benign mucosal diseases.

Chiou, *et al*.,\[[@ref107]\] in his study, suggests that identification of a rare subpopulation of cancer cells, termed cancer stemcells, from oral squamous cell carcinoma (OSCC) facilitates the monitoring, therapy, or prevention of OSCC. Enriched oral cancer stem-like cells (OC-SLC) expressed stem/progenitor cell markers greatly, as also the *ABC* transporter genes (*Oct-4*, *Nanog*, *CD117*, *Nestin*, *CD133*, and *ABCG2*), which displayed enhanced migration/invasion/malignancy capabilities *in vitro* and *in vivo*. The author concluded that Nanog/Oct-4/CD133 triple-positive patients predicted the worst survival prognosis of OSCC patients.

Application of dental stem cell for regeneration of non-dental tissues {#sec2-15}
----------------------------------------------------------------------

Fang, *et al*., 2007,\[[@ref108]\] demonstrated that PDLSCs could form substantial amounts of collagen fibers and improved facial wrinkles in mice. Otaki, *et al*.,\[[@ref109]\] 2007, reported that dental pulp cells produced bone when implanted into subcutaneous sites in immunocompromised mice with HA/TCP (Hydroxy apatite/Tricalcium phosphate) powder as a carrier. Nosrat, *et al*., 2001,\[[@ref110]\] reported grafting dental pulp tissues into hemisected spinal cord increases the number of surviving motoneurons, indicating a functional bioactivity of the dental pulp--derived neurotrophic factors, rescuing motoneurons *in vivo* \[[Figure 3](#F3){ref-type="fig"}\].

![Uses of dental stem cells in regeneration of non-dental tissues](AMHSR-3-245-g003){#F3}

Conclusion {#sec1-5}
==========

The current research on dental stem cells is expanding at an unprecedented rate. MSC‒derived chondrocytes can be used for reconstruction of orofacial cartilage structures such as temporomandibular joint and nasal cartilage. MSC‒derived osteoblast can be used for regeneration of oral and craniofacial bones. MSC‒derived myocytes can be used to treat muscular dystrophy and facial muscle atrophy. MSC‒derived adipocytes have the ability to repair damaged cardiac tissues following a heart attack. It is now possible to cryopreserve healthy teeth as sources of autogenous stem cells, either when they are exfoliated or by extraction, because the opportunity to bank a patient\'s dental stem cells will have the greatest future impact if seized when patients are young and healthy, for future regenerative therapies. The conservative treatment of life-threatening and disfiguring defects and diseases and the ability to treat currently incurable diseases are becoming a reality. To date, the research is only confined to animal models and more human research trials are needed to determine the therapeutic utility of stem cells. Stem cell costs, coverage by health insurance, and role of pharmaceutical companies, play a pivot role in determining the future of stem cells. Some applications are approved or are being reviewed by the FDA, in the United States, and equivalent regulatory agencies elsewhere.
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